A patient hands a prescription to a pharmacist, who reaches for a strip of 10 tablets that costs ₹120. The patient pauses. “Is there a cheaper option?” The pharmacist points to a generic version of the same medicine for ₹22. Other times, he says nothing because the branded option generates more profit. The patient, unsure of the generic’s quality, often buys the expensive brand. This information gap between the science of medicine and generic equivalence costs Indian families thousands or lakhs of rupees each year.
The chemical that heals
The active pharmaceutical ingredient, or salt, is the specific chemical compound that provides the therapeutic effect. It interacts with the biological system to treat ailments like high blood pressure, high blood sugar, and infection. Everything else in a tablet, fillers, binders, coating, and colourants, are excipients. They hold the tablet together and protect the salt, but they do not cure the illness.
Why prices differ
In India, the pharmaceutical market has a unique structure. Almost all products sold under a brand name are branded generics, and the original patent has expired. Companies produce the same API and market it with a brand name. Examples include Crocin (paracetamol), Glycomet (metformin), and Ecosprin (aspirin). None of these medicines is under patent. The distinction is between a heavily marketed branded product and a less marketed generic version. Most of the price difference is due to marketing investment, not a difference in the medicinal components.
Marketing studies in India show promotional spending may account for 20% to 35% of the retail price of heavily marketed branded medicines. This spending covers medical representatives’ visits, conferences, and programs for doctors’ continuing medical education. The price of medicines must cover these expenses to create preferences among doctors and loyalty among patients. Distribution margins are also typically greater for branded medicines, which motivates retailers to focus on their promotion.
Quality standards and GMP compliance
In India, generic medicines must meet the same quality benchmarks as branded versions. They are tested against the Indian Pharmacopoeiate, British Pharmacopoeia, or United States Pharmacopoeia standards. No lower quality norms apply to generics.
Saving with generics
Switching to quality generics can save Indian families between â‚ą10,000 and â‚ą2,00,000 over five to ten years per chronic patient. This applies to conditions like diabetes and hypertension, where daily medication is needed long term.
Selecting Quality Generic Medicines
Quality depends on the manufacturer’s compliance standards. A generic medicine with quality manufacturing GMP certification is equivalent to a branded medicine of quality manufacturing.